{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T13:07:47Z","timestamp":1773493667355,"version":"3.50.1"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["T32DA023356"],"award-info":[{"award-number":["T32DA023356"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R33DA061260"],"award-info":[{"award-number":["R33DA061260"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R33DA061260"],"award-info":[{"award-number":["R33DA061260"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R33DA061260"],"award-info":[{"award-number":["R33DA061260"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R33DA061260"],"award-info":[{"award-number":["R33DA061260"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R33DA061260"],"award-info":[{"award-number":["R33DA061260"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The unpredictable and toxic nature of the unregulated drug supply poses overdose and other health risks for people who use drugs (PWUD). Drug checking services can reduce risks by identifying adulterants in individuals\u2019 drug supplies. In the United States (U.S.), DCS are increasingly offered through community harm reduction services that provide evidence-based risk reduction services for PWUD, such as syringe services programs (SSPs). However, PWUD face several multi-level barriers to consistently utilizing DCS and engaging in post-DCS safer drug use behaviors (e.g., discard, use less, avoid using alone, etc.). Staff from a San Diego-based mobile SSP and researchers drew from Social Cognitive Theory and the Social Ecological Model to develop a motivational-interviewing adjunctive intervention (MI-CHANCE) led by peers with lived substance use experience to address multi-level barriers and promote DCS engagement and adoption of post-DCS safer drug use behaviors among PWUD.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We employ a hybrid type-1 effectiveness\u2013implementation trial with a primary goal of determining effectiveness of the MI-CHANCE adjunctive intervention in increasing DCS utilization (primary behavioral outcome) and safer drug use behaviors (secondary behavioral outcome), leading to reduced overdose risk (primary health outcome) and HIV\/HCV incidence (secondary health outcome). We will recruit, consent, conduct a baseline interview, and randomize 588 PWUD who used opioids or stimulants within the week prior to receive either MI-CHANCE or an attention-control standard-of-care condition. All participants will be offered DCS following exposure to the intervention or control condition. We will conduct six-month follow-up with participants over a 30-month period to collect outcomes and hypothesized predictors, mediators and potential confounders. Our secondary goal is to assess MI-CHANCE implementation considerations guided by the RE-AIM\/PRISM framework via annual in-depth interviews over the course of the trial with SSP staff (<jats:italic>N<\/jats:italic>\u2009=\u20095) and participants (<jats:italic>N<\/jats:italic>\u2009=\u200920), focusing on acceptability and feasibility, and the potential for scalability via interviews with a broad sample of diverse U.S. SSPs (<jats:italic>N<\/jats:italic>\u2009=\u200920).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Discussion<\/jats:title>\n            <jats:p>This hybrid trial will advance crucial knowledge on the effectiveness and implementation of an adjunctive intervention to promote DCS engagement and safer drug use behaviors to reduce overdose risk among PWUD.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Trial registration<\/jats:title>\n            <jats:p>ClinicalTrials.gov, NCT06855836. Registered February 28, 2025. <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/clinicaltrials.gov\/study\/NCT06855836?term=NCT06855836\/rank=1\" ext-link-type=\"uri\">https:\/\/clinicaltrials.gov\/study\/NCT06855836?term=NCT06855836\/rank=1<\/jats:ext-link>.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12889-025-24460-y","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T11:42:13Z","timestamp":1759232533000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Motivational interviewing to increase drug checking and reduce overdose rates among people who use drugs: protocol for a hybrid type 1 effectiveness\u2013implementation trial of an adjunctive intervention"],"prefix":"10.1186","volume":"25","clinical-trial-number":[{"clinical-trial-number":"nct06855836","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Katie","family":"Bailey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steffanie A.","family":"Strathdee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela R.","family":"Bazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tara","family":"Stamos-Buesig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morgan","family":"Godvin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Harvey-Vera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Abramovitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos F.","family":"Vera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas L.","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J.","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annick","family":"B\u00f3rquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"key":"24460_CR1","unstructured":"Ahmad F, Cisewski J, Rossen L, Sutton, Center for Health Statistics. Provisional Drug Overdose Death Counts. National; 2025. https:\/\/www.cdc.gov\/nchs\/nvss\/vsrr\/drug-overdose-data.htm Accessed 27 Jan 2025."},{"key":"24460_CR2","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.drugpo.2019.01.010","volume":"71","author":"D Ciccarone","year":"2019","unstructured":"Ciccarone D. The triple wave epidemic: supply and demand drivers of the US opioid overdose crisis. Int J Drug Policy. 2019;71:183\u20138. https:\/\/doi.org\/10.1016\/j.drugpo.2019.01.010.","journal-title":"Int J Drug Policy"},{"key":"24460_CR3","unstructured":"United States Drug Enforcement Administration. 2017 National drug threat assessment. U.S. Department of Justice; 2017."},{"key":"24460_CR4","unstructured":"Dashboard CDCSUDORS. Fatal Drug Overdose Data. Overdose Prevention. December 12, 2024. https:\/\/www.cdc.gov\/overdose-prevention\/data-research\/facts-stats\/sudors-dashboard-fatal-overdose-data.html Accessed 27 Jan 2025."},{"issue":"6","key":"24460_CR5","doi-asserted-by":"publisher","first-page":"e40736","DOI":"10.7759\/cureus.40736","volume":"15","author":"J Pergolizzi","year":"2023","unstructured":"Pergolizzi J, Raffa R, LeQuang JAK, Breve F, Varrassi G. Old drugs and new challenges: A narrative review of nitazenes. Cureus. 2023;15(6):e40736. https:\/\/doi.org\/10.7759\/cureus.40736.","journal-title":"Cureus"},{"issue":"12","key":"24460_CR6","doi-asserted-by":"publisher","first-page":"e2451951","DOI":"10.1001\/jamanetworkopen.2024.51951","volume":"7","author":"D Kuai","year":"2024","unstructured":"Kuai D, Rivera Blanco LE, Krotulski A, et al. Identification and health risks of an emerging means of drug use in correctional facilities. JAMA Netw Open. 2024;7(12):e2451951. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.51951.","journal-title":"JAMA Netw Open"},{"key":"24460_CR7","unstructured":"United States Drug Enforcement Administration. Public Safety Alert: DEA Reports Widespread Threat of Fentanyl Mixed with Xylazine. U.S. Department of Justice. https:\/\/www.dea.gov\/alert\/dea-reports-widespread-threat-fentanyl-mixed-xylazine Accessed 4 Feb 2025."},{"issue":"8","key":"24460_CR8","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.2105\/AJPH.2022.306881","volume":"112","author":"RS Alexander","year":"2022","unstructured":"Alexander RS, Canver BR, Sue KL, Morford KL. Xylazine and overdoses: trends, concerns, and recommendations. Am J Public Health. 2022;112(8):1212\u20136. https:\/\/doi.org\/10.2105\/AJPH.2022.306881.","journal-title":"Am J Public Health"},{"issue":"11","key":"24460_CR9","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.jhsa.2024.07.017","volume":"49","author":"K Naidu","year":"2024","unstructured":"Naidu K, Morales CZ, Card EB, Lin IC. Increasing prevalence of xylazine and worsening Upper-Extremity wounds in injection drug use: A local phenomenon with National implications. J Hand Surg. 2024;49(11):1129\u201335. https:\/\/doi.org\/10.1016\/j.jhsa.2024.07.017.","journal-title":"J Hand Surg"},{"key":"24460_CR10","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.drugpo.2017.05.050","volume":"46","author":"L Beletsky","year":"2017","unstructured":"Beletsky L, Davis CS. Today\u2019s Fentanyl crisis: prohibition\u2019s iron law, revisited. Int J Drug Policy. 2017;46:156\u20139. https:\/\/doi.org\/10.1016\/j.drugpo.2017.05.050.","journal-title":"Int J Drug Policy"},{"key":"24460_CR11","unstructured":"Brunt T. Drug Checking as a Harm Reduction Tool for Recreational Drug Users: Opportunities and Challenges. European Monitoring Centre for Drugs and Drug Addiction; 2017. https:\/\/www.emcdda.europa.eu\/system\/files\/attachments\/6339\/EuropeanResponsesGuide2017_BackgroundPaper-Drug-checking-harm-reduction_0.pdf."},{"issue":"3","key":"24460_CR12","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/add.15734","volume":"117","author":"N Maghsoudi","year":"2022","unstructured":"Maghsoudi N, Tanguay J, Scarfone K, et al. Drug checking services for people who use drugs: a systematic review. Addiction. 2022;117(3):532\u201344. https:\/\/doi.org\/10.1111\/add.15734.","journal-title":"Addiction"},{"issue":"1","key":"24460_CR13","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12954-018-0252-8","volume":"15","author":"M Karamouzian","year":"2018","unstructured":"Karamouzian M, Dohoo C, Forsting S, McNeil R, Kerr T, Lysyshyn M. Evaluation of a Fentanyl drug checking service for clients of a supervised injection facility, vancouver, Canada. Harm Reduct J. 2018;15(1):46. https:\/\/doi.org\/10.1186\/s12954-018-0252-8.","journal-title":"Harm Reduct J"},{"key":"24460_CR14","doi-asserted-by":"publisher","first-page":"104086","DOI":"10.1016\/j.drugpo.2023.104086","volume":"118","author":"K Bailey","year":"2023","unstructured":"Bailey K, Abramovitz D, Artamonova I, et al. Drug checking in the Fentanyl era: utilization and interest among people who inject drugs in San diego, California. Int J Drug Policy. 2023;118:104086. https:\/\/doi.org\/10.1016\/j.drugpo.2023.104086.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"24460_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12954-018-0276-0","volume":"16","author":"JE Goldman","year":"2019","unstructured":"Goldman JE, Waye KM, Periera KA, Krieger MS, Yedinak JL, Marshall BDL. Perspectives on rapid Fentanyl test strips as a harm reduction practice among young adults who use drugs: a qualitative study. Harm Reduct J. 2019;16(1):3. https:\/\/doi.org\/10.1186\/s12954-018-0276-0.","journal-title":"Harm Reduct J"},{"issue":"1","key":"24460_CR16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12954-018-0213-2","volume":"15","author":"MS Krieger","year":"2018","unstructured":"Krieger MS, Yedinak JL, Buxton JA, et al. High willingness to use rapid Fentanyl test strips among young adults who use drugs. Harm Reduct J. 2018;15(1):7. https:\/\/doi.org\/10.1186\/s12954-018-0213-2.","journal-title":"Harm Reduct J"},{"key":"24460_CR17","doi-asserted-by":"publisher","first-page":"102900","DOI":"10.1016\/j.drugpo.2020.102900","volume":"84","author":"NP Weicker","year":"2020","unstructured":"Weicker NP, Owczarzak J, Urquhart G, et al. Agency in the Fentanyl era: exploring the utility of Fentanyl test strips in an opaque drug market. Int J Drug Policy. 2020;84:102900. https:\/\/doi.org\/10.1016\/j.drugpo.2020.102900.","journal-title":"Int J Drug Policy"},{"key":"24460_CR18","doi-asserted-by":"publisher","first-page":"103147","DOI":"10.1016\/j.drugpo.2021.103147","volume":"92","author":"MK Reed","year":"2021","unstructured":"Reed MK, Roth AM, Tabb LP, Groves AK, Lankenau SE. I probably got a minute: perceptions of Fentanyl test strip use among people who use stimulants. Int J Drug Policy. 2021;92:103147. https:\/\/doi.org\/10.1016\/j.drugpo.2021.103147.","journal-title":"Int J Drug Policy"},{"key":"24460_CR19","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.drugpo.2019.03.003","volume":"68","author":"SG Sherman","year":"2019","unstructured":"Sherman SG, Morales KB, Park JN, McKenzie M, Marshall BDL, Green TC. Acceptability of implementing community-based drug checking services for people who use drugs in three united States cities: baltimore, Boston and Providence. Int J Drug Policy. 2019;68:46\u201353. https:\/\/doi.org\/10.1016\/j.drugpo.2019.03.003.","journal-title":"Int J Drug Policy"},{"key":"24460_CR20","unstructured":"CDC. Safety and Effectiveness of Syringe Services Programs. Syringe Services Programs (SSPs). September 27, 2024. https:\/\/www.cdc.gov\/syringe-services-programs\/php\/safety-effectiveness.html Accessed 10 Apr 2025."},{"issue":"33","key":"24460_CR21","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.15585\/mmwr.mm6933a2","volume":"69","author":"BH Lambdin","year":"2020","unstructured":"Lambdin BH, Bluthenthal RN, Wenger LD, et al. Overdose education and Naloxone distribution within syringe service Programs\u2014United states, 2019. Morb Mortal Wkly Rep. 2020;69(33):1117\u201321. https:\/\/doi.org\/10.15585\/mmwr.mm6933a2.","journal-title":"Morb Mortal Wkly Rep"},{"issue":"23","key":"24460_CR22","doi-asserted-by":"publisher","first-page":"15978","DOI":"10.3390\/ijerph192315978","volume":"19","author":"S Davis","year":"2022","unstructured":"Davis S, Wallace B, Van Roode T, Hore D. Substance use stigma and community drug checking: A qualitative study examining barriers and possible responses. Int J Environ Res Public Health. 2022;19(23):15978. https:\/\/doi.org\/10.3390\/ijerph192315978.","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"24460_CR23","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12954-020-00373-4","volume":"17","author":"B Wallace","year":"2020","unstructured":"Wallace B, van Roode T, Pagan F, et al. What is needed for implementing drug checking services in the context of the overdose crisis? A qualitative study to explore perspectives of potential service users. Harm Reduct J. 2020;17(1):29. https:\/\/doi.org\/10.1186\/s12954-020-00373-4.","journal-title":"Harm Reduct J"},{"issue":"1","key":"24460_CR24","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12954-023-00882-y","volume":"20","author":"C Grace Rose","year":"2023","unstructured":"Grace Rose C, Pickard AS, Kulbokas V, et al. A qualitative assessment of key considerations for drug checking service implementation. Harm Reduct J. 2023;20(1):151.","journal-title":"Harm Reduct J"},{"issue":"4","key":"24460_CR25","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.annemergmed.2023.11.020","volume":"83","author":"LM Westafer","year":"2024","unstructured":"Westafer LM, Beck SA, Simon C, Potee B, Soares WE, Schoenfeld EM. Barriers and facilitators to harm reduction for opioid use disorder: A qualitative study of people with lived experience. Ann Emerg Med. 2024;83(4):340\u201350. https:\/\/doi.org\/10.1016\/j.annemergmed.2023.11.020.","journal-title":"Ann Emerg Med"},{"issue":"1","key":"24460_CR26","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13012-024-01345-z","volume":"19","author":"JD Smith","year":"2024","unstructured":"Smith JD, Li DH, Merle JL, Keiser B, Mustanski B, Benbow ND. Adjunctive interventions: change methods directed at recipients that support uptake and use of health innovations. Implement Sci. 2024;19(1):10. https:\/\/doi.org\/10.1186\/s13012-024-01345-z.","journal-title":"Implement Sci"},{"issue":"3","key":"24460_CR27","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/MLR.0b013e3182408812","volume":"50","author":"GM Curran","year":"2012","unstructured":"Curran GM, Bauer M, Mittman B, Pyne JM, Stetler C. Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact. Med Care. 2012;50(3):217\u201326. https:\/\/doi.org\/10.1097\/MLR.0b013e3182408812.","journal-title":"Med Care"},{"key":"24460_CR28","doi-asserted-by":"publisher","unstructured":"Curran GM, Landes SJ, McBain SA, et al. Reflections on 10 years of effectiveness-implementation hybrid studies. Front Health Serv. 2022;2. https:\/\/doi.org\/10.3389\/frhs.2022.1053496.","DOI":"10.3389\/frhs.2022.1053496"},{"key":"24460_CR29","doi-asserted-by":"publisher","unstructured":"Glasgow RE, Harden SM, Gaglio B, et al. RE-AIM planning and evaluation framework: adapting to new science and practice with a 20-Year review. Front Public Health. 2019;7. https:\/\/doi.org\/10.3389\/fpubh.2019.00064.","DOI":"10.3389\/fpubh.2019.00064"},{"key":"24460_CR30","unstructured":"California Department of Public Health. California Overdose Surveillance Dashboard. California Overdose Surveillance Dashboard. https:\/\/skylab.cdph.ca.gov\/ODdash\/ Accessed 10 Feb 2025."},{"key":"24460_CR31","unstructured":"White House Office of National Drug Control Policy. High Intensity Drug Trafficking Areas (HIDTA). 2025. https:\/\/www.hidtaprogram.org\/ Accessed 11 Feb 2025."},{"key":"24460_CR32","unstructured":"Jones-Sawyer R. AB-2136. Controlled Substances: Analyzing and Testing; 2024."},{"key":"24460_CR33","unstructured":"Alpert Reyes E. They\u2019re not trying to die: How drug checking aims to protect users in a messy market. Los Angeles Times. May 22, 2022. https:\/\/www.latimes.com\/california\/story\/2022-05-22\/overdoses-drug-checking-aims-to-protect-users Accessed 4 Feb 2023."},{"key":"24460_CR34","doi-asserted-by":"publisher","first-page":"102661","DOI":"10.1016\/j.drugpo.2020.102661","volume":"77","author":"TC Green","year":"2020","unstructured":"Green TC, Park JN, Gilbert M, et al. An assessment of the limits of detection, sensitivity and specificity of three devices for public health-based drug checking of Fentanyl in street-acquired samples. Int J Drug Policy. 2020;77:102661. https:\/\/doi.org\/10.1016\/j.drugpo.2020.102661.","journal-title":"Int J Drug Policy"},{"key":"24460_CR35","doi-asserted-by":"publisher","first-page":"109001","DOI":"10.1016\/j.drugalcdep.2021.109001","volume":"227","author":"M Kariisa","year":"2021","unstructured":"Kariisa M, Seth P, Scholl L, Wilson N, Davis NL. Drug overdose deaths involving cocaine and psychostimulants with abuse potential among Racial and ethnic groups - United states, 2004\u20132019. Drug Alcohol Depend. 2021;227:109001. https:\/\/doi.org\/10.1016\/j.drugalcdep.2021.109001.","journal-title":"Drug Alcohol Depend"},{"key":"24460_CR36","doi-asserted-by":"publisher","first-page":"109644","DOI":"10.1016\/j.drugalcdep.2022.109644","volume":"240","author":"K Bailey","year":"2022","unstructured":"Bailey K, Abramovitz D, Patterson TL, et al. Correlates of recent overdose among people who inject drugs in the San diego\/tijuana border region. Drug Alcohol Depend. 2022;240:109644. https:\/\/doi.org\/10.1016\/j.drugalcdep.2022.109644.","journal-title":"Drug Alcohol Depend"},{"key":"24460_CR37","unstructured":"GUIDANCE FOR CLINICAL TRIAL PROTOCOLS. https:\/\/spirit-statement.org\/ Accessed 13 May 2025."},{"issue":"4","key":"24460_CR38","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1177\/109019818801500401","volume":"15","author":"KR McLeroy","year":"1988","unstructured":"McLeroy KR, Bibeau D, Steckler A, Glanz K. An ecological perspective on health promotion programs. Health Educ Q. 1988;15(4):351\u201377. https:\/\/doi.org\/10.1177\/109019818801500401.","journal-title":"Health Educ Q"},{"key":"24460_CR39","doi-asserted-by":"publisher","first-page":"282","DOI":"10.4278\/0890-1171-10.4.282","volume":"10","author":"D Stokols","year":"1996","unstructured":"Stokols D. Translating social ecological theory into guidelines for community health promotion. Am J Health Promotion. 1996;10:282\u201398.","journal-title":"Am J Health Promotion"},{"issue":"2","key":"24460_CR40","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1177\/1090198104263660","volume":"31","author":"A Bandura","year":"2004","unstructured":"Bandura A. Health promotion by social cognitive means. Health Educ Behav. 2004;31(2):143\u201364. https:\/\/doi.org\/10.1177\/1090198104263660.","journal-title":"Health Educ Behav"},{"issue":"7","key":"24460_CR41","doi-asserted-by":"publisher","first-page":"497","DOI":"10.7326\/0003-4819-149-7-200810070-00011","volume":"149","author":"JS Lin","year":"2008","unstructured":"Lin JS, Whitlock E, O\u2019Connor E, Bauer V. Behavioral counseling to prevent sexually transmitted infections: A systematic review for the U.S. preventive services task force. Ann Intern Med. 2008;149(7):497\u2013508. https:\/\/doi.org\/10.7326\/0003-4819-149-7-200810070-00011.","journal-title":"Ann Intern Med"},{"issue":"1","key":"24460_CR42","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13722-022-00328-z","volume":"17","author":"AR Bazzi","year":"2022","unstructured":"Bazzi AR, Harvey-Vera A, Buesig-Stamos T, et al. Study protocol for a pilot randomized controlled trial to increase COVID-19 testing and vaccination among people who inject drugs in San Diego County. Addict Sci Clin Pract. 2022;17(1):48. https:\/\/doi.org\/10.1186\/s13722-022-00328-z.","journal-title":"Addict Sci Clin Pract"},{"key":"24460_CR43","unstructured":"Miller WR, Rollnick S. Motivational interviewing: Preparing people to change addictive behavior. The Guilford Press; 1991. p. xvii."},{"issue":"8","key":"24460_CR44","doi-asserted-by":"publisher","first-page":"ofad392","DOI":"10.1093\/ofid\/ofad392","volume":"10","author":"SA Strathdee","year":"2023","unstructured":"Strathdee SA, Abramovitz D, Harvey-Vera AY, et al. A brief Peer-Led intervention to increase COVID-19 vaccine uptake among people who inject drugs in San Diego county: results from a pilot randomized controlled trial. Open Forum Infect Dis. 2023;10(8):ofad392. https:\/\/doi.org\/10.1093\/ofid\/ofad392.","journal-title":"Open Forum Infect Dis"},{"issue":"11","key":"24460_CR45","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.2105\/AJPH.2007.130096","volume":"98","author":"TL Patterson","year":"2008","unstructured":"Patterson TL, Mausbach B, Lozada R, et al. Efficacy of a brief behavioral intervention to promote condom use among female sex workers in Tijuana and Ciudad juarez, Mexico. Am J Public Health. 2008;98(11):2051\u20137. https:\/\/doi.org\/10.2105\/AJPH.2007.130096.","journal-title":"Am J Public Health"},{"issue":"6","key":"24460_CR46","doi-asserted-by":"publisher","first-page":"e65812","DOI":"10.1371\/journal.pone.0065812","volume":"8","author":"SA Strathdee","year":"2013","unstructured":"Strathdee SA, Abramovitz D, Lozada R, et al. Reductions in HIV\/STI incidence and sharing of injection equipment among female sex workers who inject drugs: results from a randomized controlled trial. PLoS ONE. 2013;8(6):e65812. https:\/\/doi.org\/10.1371\/journal.pone.0065812.","journal-title":"PLoS ONE"},{"issue":"12","key":"24460_CR47","doi-asserted-by":"publisher","first-page":"3306","DOI":"10.1007\/s10461-020-02930-1","volume":"24","author":"TL Patterson","year":"2020","unstructured":"Patterson TL, Pitpitan EV, Pines HA, et al. A randomized controlled trial of a texting intervention to maintain sexual risk reduction with clients among female sex workers in Tijuana and Ciudad juarez, Mexico. AIDS Behav. 2020;24(12):3306\u201319. https:\/\/doi.org\/10.1007\/s10461-020-02930-1.","journal-title":"AIDS Behav"},{"issue":"4","key":"24460_CR48","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1080\/15332640.2013.836730","volume":"12","author":"CS Lee","year":"2013","unstructured":"Lee CS, L\u00f3pez SR, Colby SM, et al. Culturally adapted motivational interviewing for Latino heavy drinkers: results from a randomized clinical trial. J Ethn Subst Abuse. 2013;12(4):356\u201373. https:\/\/doi.org\/10.1080\/15332640.2013.836730.","journal-title":"J Ethn Subst Abuse"},{"key":"24460_CR49","unstructured":"U.S. Census Bureau. QuickFacts: San Diego County, California. 2023. https:\/\/www.census.gov\/quickfacts\/fact\/table\/sandiegocountycalifornia\/PST045222 Accessed 24 Mar 2024."},{"issue":"22","key":"24460_CR50","doi-asserted-by":"publisher","first-page":"12073","DOI":"10.3390\/ijerph182212073","volume":"18","author":"F Mercer","year":"2021","unstructured":"Mercer F, Miler JA, Pauly B, et al. Peer support and overdose prevention responses: A systematic \u2018State-of-the-Art\u2019 review. Int J Environ Res Public Health. 2021;18(22):12073. https:\/\/doi.org\/10.3390\/ijerph182212073.","journal-title":"Int J Environ Res Public Health"},{"key":"24460_CR51","unstructured":"U.S. Substance Abuse and Mental Health Services. Chapter 3\u2014Motivational Interviewing as a Counseling Style. In: Enhancing Motivation for Change in Substance Use Disorder Treatment: Updated 2019. Treatment Improvement Protocol (TIP) Series. Lulu.com. 2019. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK571068\/ Accessed 5 May 2025."},{"key":"24460_CR52","doi-asserted-by":"publisher","first-page":"g1687","DOI":"10.1136\/bmj.g1687","volume":"348","author":"TC Hoffmann","year":"2014","unstructured":"Hoffmann TC, Glasziou PP, Boutron I, et al. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ. 2014;348:g1687. https:\/\/doi.org\/10.1136\/bmj.g1687.","journal-title":"BMJ"},{"key":"24460_CR53","doi-asserted-by":"publisher","first-page":"111053","DOI":"10.1016\/j.drugalcdep.2023.111053","volume":"255","author":"CE Megerian","year":"2024","unstructured":"Megerian CE, Bair L, Smith J, et al. Health risks associated with smoking versus injecting Fentanyl among people who use drugs in California. Drug Alcohol Depend. 2024;255:111053. https:\/\/doi.org\/10.1016\/j.drugalcdep.2023.111053.","journal-title":"Drug Alcohol Depend"},{"key":"24460_CR54","unstructured":"SAS Institute Inc. SAS\/STAT\u00ae 9.3 User\u2019s Guide: The PLAN Procedure. Published online 2011. https:\/\/support.sas.com\/documentation\/onlinedoc\/stat\/930\/"},{"issue":"1","key":"24460_CR55","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.explore.2004.11.001","volume":"1","author":"D Moher","year":"2005","unstructured":"Moher D, Schulz KF, Altman D. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials 2001. EXPLORE. 2005;1(1):40\u20135. https:\/\/doi.org\/10.1016\/j.explore.2004.11.001.","journal-title":"EXPLORE"},{"key":"24460_CR56","unstructured":"Miriad Rapid HBc\/HIV\/HCV Antibody Test, LAB\u2009+\u2009Format MMVWR. https:\/\/us.vwr.com\/store\/product\/12446852\/miriad-rapid-hbc-hiv-hcv-antibody-test-lab-format-medmira Accessed 24 Mar 2024."},{"key":"24460_CR57","unstructured":"Rapid Infectious Disease Products. OraSure Technologies. https:\/\/orasure.com\/products-infectious\/index.html Accessed 24 Mar 2024."},{"key":"24460_CR58","doi-asserted-by":"publisher","first-page":"Doc01","DOI":"10.3205\/psm000091","volume":"10","author":"M Romppel","year":"2013","unstructured":"Romppel M, Herrmann-Lingen C, Wachter R, et al. A short form of the general Self-Efficacy scale (GSE-6): development, psychometric properties and validity in an intercultural non-clinical sample and a sample of patients at risk for heart failure. Psychosoc Med. 2013;10:Doc01. https:\/\/doi.org\/10.3205\/psm000091.","journal-title":"Psychosoc Med"},{"issue":"Suppl 1","key":"24460_CR59","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1016\/j.drugalcdep.2007.05.007","volume":"91","author":"RS Garfein","year":"2007","unstructured":"Garfein RS, Swartzendruber A, Ouellet LJ, et al. Methods to recruit and retain a cohort of young-adult injection drug users for the third collaborative injection drug users study\/drug users intervention trial (CIDUS III\/DUIT). Drug Alcohol Depend. 2007;91(Suppl 1):S4\u201317. https:\/\/doi.org\/10.1016\/j.drugalcdep.2007.05.007.","journal-title":"Drug Alcohol Depend"},{"issue":"11","key":"24460_CR60","doi-asserted-by":"publisher","first-page":"3629","DOI":"10.1007\/s10461-024-04433-9","volume":"28","author":"K Bailey","year":"2024","unstructured":"Bailey K, Abramovitz D, Rangel G, et al. Safe injection Self-Efficacy is associated with HCV and HIV seropositivity among people who inject drugs in the San Diego\u2013Tijuana border region. AIDS Behav. 2024;28(11):3629\u201342. https:\/\/doi.org\/10.1007\/s10461-024-04433-9.","journal-title":"AIDS Behav"},{"issue":"3","key":"24460_CR61","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s10654-019-00494-6","volume":"34","author":"TJ VanderWeele","year":"2019","unstructured":"VanderWeele TJ. Principles of confounder selection. Eur J Epidemiol. 2019;34(3):211\u20139. https:\/\/doi.org\/10.1007\/s10654-019-00494-6.","journal-title":"Eur J Epidemiol"},{"issue":"2","key":"24460_CR62","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1177\/0165025417727876","volume":"42","author":"GJ Geldhof","year":"2018","unstructured":"Geldhof GJ, Anthony KP, Selig JP, Mendez-Luck CA. Accommodating binary and count variables in mediation: A case for conditional indirect effects. Int J Behav Dev. 2018;42(2):300\u20138. https:\/\/doi.org\/10.1177\/0165025417727876.","journal-title":"Int J Behav Dev"},{"issue":"9","key":"24460_CR63","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.2105\/AJPH.89.9.1322","volume":"89","author":"RE Glasgow","year":"1999","unstructured":"Glasgow RE, Vogt TM, Boles SM. Evaluating the public health impact of health promotion interventions: the RE-AIM framework. Am J Public Health. 1999;89(9):1322\u20137. https:\/\/doi.org\/10.2105\/AJPH.89.9.1322.","journal-title":"Am J Public Health"},{"issue":"1","key":"24460_CR64","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1177\/1525822X05279903","volume":"18","author":"G Guest","year":"2006","unstructured":"Guest G, Bunce A, Johnson L. How many interviews are enough?? An experiment with data saturation and variability. Field Methods. 2006;18(1):59\u201382.","journal-title":"Field Methods"},{"key":"24460_CR65","unstructured":"Johnson JC. Selecting ethnographic informants. Sage Publications, Inc; 1990. p. 96."},{"issue":"1","key":"24460_CR66","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13012-017-0635-3","volume":"12","author":"BJ Weiner","year":"2017","unstructured":"Weiner BJ, Lewis CC, Stanick C, et al. Psychometric assessment of three newly developed implementation outcome measures. Implement Sci. 2017;12(1):108. https:\/\/doi.org\/10.1186\/s13012-017-0635-3.","journal-title":"Implement Sci"},{"issue":"2","key":"24460_CR67","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10488-010-0319-7","volume":"38","author":"E Proctor","year":"2011","unstructured":"Proctor E, Silmere H, Raghavan R, et al. Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda. Adm Policy Ment Health. 2011;38(2):65\u201376. https:\/\/doi.org\/10.1007\/s10488-010-0319-7.","journal-title":"Adm Policy Ment Health"},{"key":"24460_CR68","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1471-2393-9-46","volume":"9","author":"JP Ruger","year":"2009","unstructured":"Ruger JP, Emmons KM, Kearney MH, Weinstein MC. Measuring the costs of outreach motivational interviewing for smoking cessation and relapse prevention among low-income pregnant women. BMC Pregnancy Childbirth. 2009;9:46. https:\/\/doi.org\/10.1186\/1471-2393-9-46.","journal-title":"BMC Pregnancy Childbirth"},{"key":"24460_CR69","doi-asserted-by":"publisher","first-page":"108336","DOI":"10.1016\/j.drugalcdep.2020.108336","volume":"217","author":"AP Aldridge","year":"2020","unstructured":"Aldridge AP, Barbosa C, Barocas JA, et al. Health economic design for cost, cost-effectiveness and simulation analyses in the healing communities study. Drug Alcohol Depend. 2020;217:108336. https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.108336.","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"24460_CR70","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1177\/15586898221126816","volume":"17","author":"K Proudfoot","year":"2023","unstructured":"Proudfoot K. Inductive\/Deductive hybrid thematic analysis in mixed methods research. J Mixed Methods Res. 2023;17(3):308\u201326. https:\/\/doi.org\/10.1177\/15586898221126816.","journal-title":"J Mixed Methods Res"},{"issue":"1","key":"24460_CR71","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1177\/160940690600500107","volume":"5","author":"J Fereday","year":"2006","unstructured":"Fereday J, Muir-Cochrane E. Demonstrating rigor using thematic analysis: A hybrid approach of inductive and deductive coding and theme development. Int J Qual Methods. 2006;5(1):80\u201392. https:\/\/doi.org\/10.1177\/160940690600500107.","journal-title":"Int J Qualitative Methods"},{"issue":"2","key":"24460_CR72","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1177\/004912418101000205","volume":"10","author":"P Biernacki","year":"1981","unstructured":"Biernacki P, Waldorf D. Snowball sampling: problems and techniques of chain referral sampling. Sociol Methods Res. 1981;10(2):141\u201363. https:\/\/doi.org\/10.1177\/004912418101000205.","journal-title":"Sociol Methods Res"},{"key":"24460_CR73","unstructured":"NASEN. NASEN | North America Syringe Exchange Network: NASEN Directory. https:\/\/nasen.org Accessed 13 Apr 2025."},{"key":"24460_CR74","unstructured":"World Health Organization, ExpandNet. Nine steps for developing a scaling-up strategy. In: Nine Steps for Developing a Scaling-up Strategy. 2010. https:\/\/www.who.int\/publications\/i\/item\/9789241500319 Accessed 27 Apr 2025."},{"issue":"1","key":"24460_CR75","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13012-015-0209-1","volume":"10","author":"BJ Powell","year":"2015","unstructured":"Powell BJ, Waltz TJ, Chinman MJ, et al. A refined compilation of implementation strategies: results from the expert recommendations for implementing change (ERIC) project. Implement Sci. 2015;10(1):21. https:\/\/doi.org\/10.1186\/s13012-015-0209-1.","journal-title":"Implement Sci"},{"key":"24460_CR76","doi-asserted-by":"publisher","first-page":"107755872513169","DOI":"10.1177\/10775587251316919","volume":"12","author":"M Bhai","year":"2025","unstructured":"Bhai M, McMichael BJ, Mitchell DT. Impact of Fentanyl test strips as harm reduction for Drug-Related mortality. Med Care Res Rev. 2025;12:10775587251316919. https:\/\/doi.org\/10.1177\/10775587251316919.","journal-title":"Med Care Res Rev Published Online Febr"},{"key":"24460_CR77","doi-asserted-by":"publisher","first-page":"109425","DOI":"10.1016\/j.drugalcdep.2022.109425","volume":"234","author":"CS Davis","year":"2022","unstructured":"Davis CS, Lieberman AJ, O\u2019Kelley-Bangsberg M. Legality of drug checking equipment in the united states: A systematic legal analysis. Drug Alcohol Depend. 2022;234:109425. https:\/\/doi.org\/10.1016\/j.drugalcdep.2022.109425.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"24460_CR78","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12954-022-00590-z","volume":"19","author":"JJ Carroll","year":"2022","unstructured":"Carroll JJ, Mackin S, Schmidt C, McKenzie M, Green TC. The bronze age of drug checking: barriers and facilitators to implementing advanced drug checking amidst Police violence and COVID-19. Harm Reduct J. 2022;19(1):9. https:\/\/doi.org\/10.1186\/s12954-022-00590-z.","journal-title":"Harm Reduct J"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-24460-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-025-24460-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-24460-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T11:42:17Z","timestamp":1759232537000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-025-24460-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["24460"],"URL":"https:\/\/doi.org\/10.1186\/s12889-025-24460-y","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"assertion":[{"value":"8 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Study procedures were approved by The University of California San Diego Institutional Review Board (IRB) on May 29, 2024 (protocol # 810285).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"3228"}}